...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Name Confusion
6
Jul 17, 2020 01:31PM
2
Jul 22, 2020 12:06PM
3
Jul 22, 2020 12:14PM
3
Jul 22, 2020 01:59PM
1
Jul 22, 2020 03:14PM
1
Jul 25, 2020 12:13PM
2
Jul 25, 2020 04:34PM
2
Jul 25, 2020 04:39PM
1
Jul 26, 2020 09:29PM
4
Jul 29, 2020 08:59AM
3
Jul 29, 2020 10:58AM
3
Jul 29, 2020 11:24AM
3
Jul 29, 2020 11:36AM
4
Jul 29, 2020 11:43AM
5
Jul 29, 2020 11:57AM
3
Jul 29, 2020 12:37PM
6
Jul 29, 2020 01:00PM
4
Jul 29, 2020 01:21PM
2
Jul 29, 2020 03:20PM
3
Aug 12, 2020 08:47AM

fuzzyjr - I know it is taking forever and not only RVX to blame. This is a clear example of why the Vancouver company should never have been able to use that name. I have talked to iTrade and had a hard time getting them to admit that it was two unrelated companies. Everything is cross-linked between them, even the CUSIP so they just kept searching different ways and kept coming up with the same thing. After a long discussion and me pointing out what our ZCC shares go for in PP's, etc., what the different products were at each and that one was based in Vancouver and one in Calgary, they loosened some. They have now read the comany's explanation in the website FAQ's and understand that ZEL is a fully owned subsidiary of ZCC. They have now said that they will delve into it and try to clear it up then get back to me but has been a couple of weeks so far with no reply. 

3
Aug 12, 2020 02:22PM
3
Aug 12, 2020 03:04PM
Share
New Message
Please login to post a reply